We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 39

NASDAQ Biotechnology Index surpasses all-time high in 1Q13
  • Shook Hardy & Bacon LLP
  • USA
  • May 16 2013

The NASDAQ Biotechnology Index reportedly rose in the first quarter of 2013 (1Q13) above levels last seen during the 2000 genomics bubble peakthe


Biotech IPO market, booming or bubbling?
  • Shook Hardy & Bacon LLP
  • USA
  • October 17 2013

Speakers at a recent Biotechnology Industry Organization (BIO) Investor Forum in San Francisco reportedly claimed that this year's successes for


North Carolina life sciences companies attract more than $1.1 billion in investments, grants
  • Shook Hardy & Bacon LLP
  • USA
  • May 19 2011

After conducting its yearly survey of media reports, a North Carolina trade association has announced that life sciences companies brought in more than $1.1 billion in investments and grants to the state in the 12 months ending April 25, 2011, representing a 25 percent increase over the 12-month period ending April 2010


Moneytree report shows increased life sciences investments in Q1 2011
  • Shook Hardy & Bacon LLP
  • USA
  • May 19 2011

According to a PricewaterhouseCoopers report on venture capital investments, although fewer deals occurred in the first quarter of 2011 (Q1 2011) as compared to the last quarter of 2010, investment activity increased 5 percent overall


Mergers affect Boston biotech independence
  • Shook Hardy & Bacon LLP
  • USA
  • April 21 2011

Biotech company executives meeting recently in Boston, were reportedly concerned about the growing buy-out trend among area businesses


Joint venture to create algae for biofuels
  • Shook Hardy & Bacon LLP
  • USA
  • April 21 2011

Bard Holding Inc. and Algae Bioenergy Solutions (ABS) have announced a joint venture to develop an algae production facility in Augusta, Georgia


Chinese billionaire backs U.S.China biopharma venture
  • Shook Hardy & Bacon LLP
  • China, USA
  • April 21 2011

Chinese real-estate billionaire Qi Jinzing has reportedly begun investing in the biotech sector despite its potential financial risks


Barbados launches biotech initiative designed to shorten R&D process
  • Shook Hardy & Bacon LLP
  • Barbados
  • December 16 2010

The Barbados government has recently launched two initiatives to attract biotech companies to the island nation


Israeli biotechnology startups seek partnerships in Ohio
  • Shook Hardy & Bacon LLP
  • USA
  • December 16 2010

Israeli biotechnology companies are reportedly heading to Ohio because of state incentives and a venture capital fund focused on investing in Israel


Viropharma to acquire Swedish pharma in deal worth up to $164.6 million
  • Shook Hardy & Bacon LLP
  • USA
  • November 3 2011

Pennsylvania-based ViroPharma Inc. has reportedly signed a deal to acquire Swedish company DuoCort Pharma AB to expand its orphan disease commercial product pipeline